A MHC Class I & II Deficient Platform Humanized with PBMCs
JAX NSG-MHC I/II KO mice readily engraft tumors and human PBMCs, have delayed GvHD, and deliver translationally-relevant results for various research applications.
Fill form to unlock content
Loading, please wait
Error - something went wrong!
JAX NSG-MHC I/II KO mice accept engraftment of tumors and human PBMCs, exhibit delayed GvHD, and deliver translationally-relevant results for a wide range of research applications, including exploratory immunology studies and preclinical therapeutic evaluation.